Table 2.
Echocardiographic parameters and cardiac biomarkers of patients
| Echocardiographic parameter | SIC (n=49) |
Non-SIC (n=259) |
P-value | ||
|---|---|---|---|---|---|
| Individual | Value | Individual | Value | ||
| Ejection fraction (%) | 49 | 34.3±8.4 | 259 | 64.7±7.5 | <0.001 |
| LVEDD (mm) | 46 | 49.6±6.0 | 248 | 43.4±6.3 | <0.001 |
| LVESD (mm) | 46 | 39.5±6.4 | 248 | 28.7±4.8 | <0.001 |
| Mitral E/e’ ratio | 36 | 12.9±5.5 | 198 | 12.0±4.3 | 0.341 |
| FAC (%) | 7 | 25.3±5.3 | 17 | 24.0±8.7 | 0.712 |
| Cardiac biomarker | |||||
| NT-proBNP (pg/ml) | 46 | 19,911.2±18,194.9 | 233 | 7,940.3±13,613.9 | <0.001 |
| CK (IU/L) | 49 | 341.7±491.8 | 245 | 635.9±3,711.8 | 0.235 |
| CK-MB (ng/ml) | 49 | 8.0±12.8 | 252 | 11.9±60.3 | 0.357 |
| Troponin-T (pg/ml) | 48 | 278.9±492.7 | 230 | 104.8±178.4 | 0.019 |
Values are presented as mean±standard deviation.
SIC: sepsis-induced cardiomyopathy; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; E: early mitral inflow velocity; e’: mitral annular early diastolic velocity; FAC: fractional area change; NT-proBNP: N-terminal pro b-type natriuretic peptide; CK: creatine kinase; CK-MB: creatine kinase-muscle/brain.